{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T12:19:24Z","timestamp":1779884364096,"version":"3.53.1"},"reference-count":37,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.3892\/or.2016.4870","type":"journal-article","created":{"date-parts":[[2016,6,13]],"date-time":"2016-06-13T10:23:04Z","timestamp":1465813384000},"page":"715-720","source":"Crossref","is-referenced-by-count":8,"title":["Rejection of adenovirus infection is independent of coxsackie and adenovirus receptor expression in cisplatin-resistant human lung cancer cells"],"prefix":"10.3892","volume":"36","author":[{"given":"Nian-Hua","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Qing","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Shi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2016,6,13]]},"reference":[{"key":"key20180107221550_b1-or-36-02-0715","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00408-015-9758-y","article-title":"Maintenance therapy improves survival outcomes in patients with advanced non-small cell lung cancer: A meta-analysis of 14 studies","volume":"193","author":"Lu","year":"2015","journal-title":"Lung"},{"key":"key20180107221550_b2-or-36-02-0715","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1309\/AJCPXGRAIMB4CTQ3","article-title":"Molecular testing for targeted therapy in advanced non-small cell lung cancer: Suitability of endobronchial ultrasound trans-bronchial needle aspiration","volume":"144","author":"Casadio","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"key20180107221550_b3-or-36-02-0715","first-page":"234","article-title":"Gene therapy for lung cancer malignant pleural effusion: Current and future nano-biotechnology","volume":"1","author":"Zarogoulidis","year":"2012","journal-title":"Transl Lung Cancer Res"},{"key":"key20180107221550_b4-or-36-02-0715","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/427779a","article-title":"The future of gene therapy","volume":"427","author":"Cavazzana-Calvo","year":"2004","journal-title":"Nature"},{"key":"key20180107221550_b5-or-36-02-0715","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2174\/157488509788185123","article-title":"Adenoviral vector-based strategies for cancer therapy","volume":"4","author":"Sharma","year":"2009","journal-title":"Curr Drug Ther"},{"key":"key20180107221550_b6-or-36-02-0715","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcb.20851","article-title":"Gene therapy for lung cancer","volume":"99","author":"Toloza","year":"2006","journal-title":"J Cell Biochem"},{"key":"key20180107221550_b7-or-36-02-0715","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1200\/JCO.2000.18.3.609","article-title":"Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer","volume":"18","author":"Nemunaitis","year":"2000","journal-title":"J Clin Oncol"},{"key":"key20180107221550_b8-or-36-02-0715","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1200\/JCO.2001.19.6.1750","article-title":"Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: Results of a multicenter phase II study","volume":"19","author":"Schuler","year":"2001","journal-title":"J Clin Oncol"},{"key":"key20180107221550_b9-or-36-02-0715","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-1-4614-8090-7_2","article-title":"The IgCAMs CAR, BT-IgSF, and CLMP: Structure, function, and diseases","volume":"8","author":"Schreiber","year":"2014","journal-title":"Adv Neurobiol"},{"key":"key20180107221550_b10-or-36-02-0715","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/S0959-8049(02)00131-4","article-title":"The therapeutic efficacy of adeno-viral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells","volume":"38","author":"Kim","year":"2002","journal-title":"Eur J Cancer"},{"key":"key20180107221550_b11-or-36-02-0715","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3892\/ijmm.2012.1133","article-title":"Coxsackievirus and adenovirus receptor promotes antitumor activity of oncolytic adenovirus H101 in esophageal cancer","volume":"30","author":"Ma","year":"2012","journal-title":"Int J Mol Med"},{"key":"key20180107221550_b12-or-36-02-0715","first-page":"325","article-title":"Loss of adenoviral receptor expression in human bladder cancer cells: A potential impact on the efficacy of gene therapy","volume":"59","author":"Li","year":"1999","journal-title":"Cancer Res"},{"key":"key20180107221550_b13-or-36-02-0715","first-page":"4208","article-title":"Factors limiting adenovirus-mediated gene transfer into human lung and pancreatic cancer cell lines","volume":"5","author":"Pearson","year":"1999","journal-title":"Clin Cancer Res"},{"key":"key20180107221550_b14-or-36-02-0715","first-page":"4992","article-title":"Coxsackievirus adenovirus receptor expression predicts the efficiency of adenoviral gene transfer into non-small cell lung cancer xenografts","volume":"9","author":"Qin","year":"2003","journal-title":"Clin Cancer Res"},{"key":"key20180107221550_b15-or-36-02-0715","first-page":"847","article-title":"Modulation of coxsackie-adenovirus receptor expression for increased adenoviral transgene expression","volume":"63","author":"Hemminki","year":"2003","journal-title":"Cancer Res"},{"key":"key20180107221550_b16-or-36-02-0715","doi-asserted-by":"crossref","first-page":"925","DOI":"10.4161\/cc.7.7.5621","article-title":"Proteasome inhibitor MG-132 modifies coxsackie and adenovirus receptor expression in colon cancer cell line lovo","volume":"7","author":"Zhang","year":"2008","journal-title":"Cell Cycle"},{"key":"key20180107221550_b17-or-36-02-0715","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1016\/j.biomaterials.2014.03.060","article-title":"Enhanced therapeutic efficacy of an adenovirus-PEI-bile-acid complex in tumors with low coxsackie and adenovirus receptor expression","volume":"35","author":"Lee","year":"2014","journal-title":"Biomaterials"},{"key":"key20180107221550_b18-or-36-02-0715","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/ijc.1453","article-title":"Drug-resistant human bladder-cancer cells are more sensitive to adenovirus-mediated wild-type p53 gene therapy compared to drug-sensitive cells","volume":"94","author":"Shirakawa","year":"2001","journal-title":"Int J Cancer"},{"key":"key20180107221550_b19-or-36-02-0715","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.molonc.2014.12.007","article-title":"Paclitaxel resistance increases oncolytic adenovirus efficacy via upregulated CAR expression and dysfunctional cell cycle control","volume":"9","author":"Ingemarsdotter","year":"2015","journal-title":"Mol Oncol"},{"key":"key20180107221550_b20-or-36-02-0715","first-page":"2846","article-title":"p53 alterations in non-small cell lung cancers correlate with metastatic involvement of hilar and mediastinal lymph nodes","volume":"53","author":"Marchetti","year":"1993","journal-title":"Cancer Res"},{"key":"key20180107221550_b21-or-36-02-0715","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/jnci\/91.9.763","article-title":"Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer","volume":"91","author":"Swisher","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"key20180107221550_b22-or-36-02-0715","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s002800050959","article-title":"Adenovirus-mediated p53 gene therapy has greater efficacy when combined with chemotherapy against human head and neck, ovarian, prostate, and breast cancer","volume":"44","author":"Gurnani","year":"1999","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20180107221550_b23-or-36-02-0715","first-page":"2887","article-title":"Synergistic inhibition of human lung cancer cell growth by adenovirus-mediated wild-type p53 gene transfer in combination with docetaxel and radiation therapeutics in vitro and in vivo","volume":"7","author":"Nishizaki","year":"2001","journal-title":"Clin Cancer Res"},{"key":"key20180107221550_b24-or-36-02-0715","first-page":"93","article-title":"Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy","volume":"9","author":"Swisher","year":"2003","journal-title":"Clin Cancer Res"},{"key":"key20180107221550_b25-or-36-02-0715","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/107155760200900310","article-title":"Adenovirus-mediated thymidine kinase gene therapy for recurrent ovarian cancer: Expression of coxsackie-adenovirus receptor and integrins alphavbeta3 and alphavbeta5","volume":"9","author":"Hasenburg","year":"2002","journal-title":"J Soc Gynecol Investig"},{"key":"key20180107221550_b26-or-36-02-0715","first-page":"8680","article-title":"Epigenetic regulation of coxsackie and adenovirus receptor (CAR) gene promoter in urogenital cancer cells","volume":"63","author":"Pong","year":"2003","journal-title":"Cancer Res"},{"key":"key20180107221550_b27-or-36-02-0715","first-page":"6328","article-title":"Enhanced adenovirus transgene expression in malignant cells treated with the histone deacetylase inhibitor FR901228","volume":"61","author":"Kitazono","year":"2001","journal-title":"Cancer Res"},{"key":"key20180107221550_b28-or-36-02-0715","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.yexcr.2005.10.026","article-title":"Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells","volume":"312","author":"Watanabe","year":"2006","journal-title":"Exp Cell Res"},{"key":"key20180107221550_b29-or-36-02-0715","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/hum.2006.17.55","article-title":"Novel three-pronged strategy to enhance cancer cell killing in glioblastoma cell lines: Histone deacetylase inhibitor, chemotherapy, and oncolytic adenovirus dl520","volume":"17","author":"Bieler","year":"2006","journal-title":"Hum Gene Ther"},{"key":"key20180107221550_b30-or-36-02-0715","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.cgt.7700905","article-title":"In vitro efficacy of AdTRAIL gene therapy of bladder cancer is enhanced by trichostatin A-mediated restoration of CAR expression and downregulation of cFLIP and Bcl-XL","volume":"13","author":"El-Zawahry","year":"2006","journal-title":"Cancer Gene Ther"},{"key":"key20180107221550_b31-or-36-02-0715","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1158\/1535-7163.MCT-07-0395","article-title":"Histone deacetylase inhibitor FK228 enhances adenovirus-mediated p53 family gene therapy in cancer models","volume":"7","author":"Sasaki","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"key20180107221550_b32-or-36-02-0715","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1158\/0008-5472.CAN-05-3017","article-title":"Histone deacetylase inhibitors modulate the sensitivity of tumor necrosis factor-related apoptosis-inducing ligand-resistant bladder tumor cells","volume":"66","author":"Earel","year":"2006","journal-title":"Cancer Res"},{"key":"key20180107221550_b33-or-36-02-0715","doi-asserted-by":"crossref","first-page":"e0127058","DOI":"10.1371\/journal.pone.0127058","article-title":"The HDAC inhibitors scriptaid and LBH589 combined with the oncolytic virus delta24-RGD exert enhanced anti-tumor efficacy in patient-derived glioblastoma cells","volume":"10","author":"Berghauser Pont","year":"2015","journal-title":"PLoS One"},{"key":"key20180107221550_b34-or-36-02-0715","first-page":"218","article-title":"Combination therapy of conditionally replicating adenovirus and histone deacetylase inhibitors","volume":"29","author":"Kim","year":"2012","journal-title":"Int J Mol Med"},{"key":"key20180107221550_b35-or-36-02-0715","doi-asserted-by":"crossref","first-page":"e14462","DOI":"10.1371\/journal.pone.0014462","article-title":"Enhancement of vaccinia virus based oncolysis with histone deacetylase inhibitors","volume":"5","author":"MacTavish","year":"2010","journal-title":"PLoS One"},{"key":"key20180107221550_b36-or-36-02-0715","doi-asserted-by":"crossref","first-page":"8047","DOI":"10.1128\/JVI.78.15.8047-8058.2004","article-title":"Cytokine-mediated downregulation of coxsackievirus-adenovirus receptor in endothelial cells","volume":"78","author":"Vincent","year":"2004","journal-title":"J Virol"},{"key":"key20180107221550_b37-or-36-02-0715","first-page":"2088","article-title":"Inhibition of the Raf\/MEK\/ERK pathway up-regulates expression of the coxsackievirus and adenovirus receptor in cancer cells","volume":"63","author":"Anders","year":"2003","journal-title":"Cancer Res"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2016.4870\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T16:41:02Z","timestamp":1656693662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2016.4870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,13]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,6,13]]},"published-print":{"date-parts":[[2016,8]]}},"alternative-id":["10.3892\/or.2016.4870"],"URL":"https:\/\/doi.org\/10.3892\/or.2016.4870","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,13]]}}}